Year: 2024
Type: article
Study design: Clinical Trial
Abstract: Background: Microtraumatic posterior shoulder instability (PSI) is characterized by symptomatic posterior translation of the glenohumeral joint. A common etiology is a gradual overload of glenohumeral joint structures. The recommend initial treatment for microtraumatic PSI is rehabilitation; however, the evidence to support this recommendation is limited. The aim of this study is to investigate the patient- reported outcome measures and return to sport success of participants with microtraumatic PSI who participate in a posterior instability rehabilitation program. Methods: In the single-group study design, 24 shoulders in 22 sporting participants (17 male, 5 females; mean age, 21.1 years, standard deviation 10.1 years) diagnosed with microtraumatic PSI undertook the Watson Posterior Instability Program (WIP-p) over 24 weeks. Outcome measures included the Melbourne Instability Shoulder Score and Western Ontario Shoulder Instability Index at baseline, 6, 12, and 24 weeks. Failure of conservative management and time to return to sport was measured. Treatment effects were determined using linear mixed models, with 95% confidence intervals. Significance was set at 0.05. Results: < .001) on the Melbourne Instability Shoulder Score. For return to sport, 20 of the 22 (90.1%) participants returned to full activity at the 24-week time point, while two went on to have reconstructive surgery. Discussion and Conclusion: The WIP-p resulted in a high level of return to sport and significantly improved functional outcomes in patients with microtraumatic PSI. A small proportion of sporting participations with microtraumatic PSI may fail conservative rehabilitation and require surgical consideration.
Source: JSES International
Authors: Lyn Watson, Simon Balster, Sarah Warby, Ross Lenssen, Gregory Hoy, Shane Barwood, Jacqui French, Bonnie Kerr, Sam Lawrence, Charlotte Ganderton, Katherine Davis, Tania Pizzari
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,250
OpenAlex ID: W4403117635
